Key Insights

Highlights

Success Rate

33% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 60/100

Termination Rate

14.3%

2 terminated out of 14 trials

Success Rate

33.3%

-53.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed with results

Key Signals

2 with results33% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (3)
P 1 (3)
P 2 (5)

Trial Status

Recruiting6
Active Not Recruiting4
Terminated2
Unknown1
Completed1

Trial Success Rate

33.3%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT02834013Phase 2Active Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02465060Phase 2Active Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02713269Phase 2Active Not Recruiting

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

NCT06207188RecruitingPrimary

Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters

NCT04742608RecruitingPrimary

Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer

NCT05229341Not ApplicableRecruitingPrimary

Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

NCT04459273Phase 1Active Not Recruiting

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT05334069Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT04593277Not ApplicableCompleted

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

NCT04589624Phase 1RecruitingPrimary

An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy

NCT07118176Phase 1Recruiting

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

NCT03463889Phase 2TerminatedPrimary

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

NCT02062632Phase 2Terminated

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

NCT03510143Not ApplicableUnknownPrimary

Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery

Showing all 14 trials

Research Network

Activity Timeline